Movatterモバイル変換


[0]ホーム

URL:


Prijeđi na sadržaj
Wikipedija
Pretraga

Ganciklovir

Izvor: Wikipedija
Ganciklovir
Klinički podaci
Robne markeCytovene, Cytovene IV, Cytovene-IV, Vitrasert
AHFS/Drugs.comMonografija
Identifikatori
CAS broj82410-32-0
ATC kodJ05AB06 ,S01AD09
PubChem[1][2]3454
DrugBankDB01004
ChemSpider[3]3336
ChEBICHEBI:465284 DaY
ChEMBL[4]CHEMBL182 DaY
Hemijski podaci
FormulaC9H13N5O4 
Mol. masa255,231
SMILESeMolekuli &PubHem
InChI
InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
Key: IRSCQMHQWWYFCW-UHFFFAOYSA-N DaY
Fizički podaci
Tačka topljenja250 °C (482 °F)
Farmakokinetički podaci
Poluvreme eliminacije2,5 - 3,6 h
IzlučivanjeRenalno
Farmakoinformacioni podaci
Trudnoća?
Pravni status
Način primeneOralno, intravenozno

Ganciklovir jeorgansko jedinjenje, koje sadrži 9atomaugljenika i imamolekulsku masu od 255,231Da.[5][6]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika8
Broj donora vodonika4
Broj rotacionih veza5
Particioni koeficijent[7] (ALogP)-1,9
Rastvorljivost[8] (logS, log(mol/L))-0,3
Polarna površina[9] (PSA,Å2)135,0

Reference

[uredi |uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682. 
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412. 
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. 
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. 

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Ganciklovir naWikimedijinoj ostavi
Izvor:https://sh.wikipedia.org/w/index.php?title=Ganciklovir&oldid=42297854
Kategorije:

[8]ページ先頭

©2009-2025 Movatter.jp